QUAVONLIMAB for Hepatocellular carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 9 adverse event reports in the FDA FAERS database where QUAVONLIMAB was used for Hepatocellular carcinoma.

Most Reported Side Effects for QUAVONLIMAB

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	26	7.1%	0	23
Anaemia	24	6.5%	1	23
Colitis	22	6.0%	0	21
Hyponatraemia	18	4.9%	2	18
Acute kidney injury	14	3.8%	0	14
Pneumonia	11	3.0%	0	11
Adrenal insufficiency	10	2.7%	1	10
Alanine aminotransferase increased	9	2.5%	1	9
Dehydration	9	2.5%	2	9
Hypertension	9	2.5%	0	7
Pyrexia	8	2.2%	0	8
Aspartate aminotransferase increased	7	1.9%	1	7
Dyspnoea	7	1.9%	0	7
General physical health deterioration	7	1.9%	0	7
Malignant neoplasm progression	7	1.9%	6	6